Pharmaceutical start-ups are increasingly using drug patent loopholes to jack up prices on old drugs. It's just one example of the wild west of drug pricing. Unlike Europe and Canada, the US doesn't negotiate the price of drugs or provide caps. Guest host Barbara Bogaev asks whether costs are out of control, and explores what should be done about it.